Late-breaking presentation at ACG 2023 showed histologic and endoscopic improvements were maintained with no new safety signals to week 52 with higher dose Dupixent in these children Data reinforce ...

Please provide your email address to receive an email when new articles are posted on . CHARLOTTE, N.C. — Dupilumab improved clinical, symptomatic, histologic and endoscopic outcomes among patients ...

PHOENIX — The opportunity to diagnose eosinophilic esophagitis (EoE) when patients present to the emergency department (ED) with the classic symptom of esophageal food impaction (EFI) is commonly ...

Please provide your email address to receive an email when new articles are posted on . At 16 weeks, 68% of patients on high-dose dupilumab achieved reduced peak eosinophil counts vs. 3% on placebo.